Why compounding is no longer allowed for routine weight management On February 21, 2025, the FDA formally determined that semaglutide injection shortages were resolved and announced short transition windows to wind down compounding of essentially a copy products
Limited studies on ipamorelin claim it did not drastically impact other hormone levels in the body
Practical Strategies to Reduce Nausea While on GLP-1 Therapy Nausea severity often correlates with dose escalation speed and meal timing
Retatrutide: The Next Breakthrough in Weight Loss and Metabolic HealthComing Soon to Pinnacle Performance Labs Pinnacle Performance Labs Mar 15, 2025 2 min read Updated: Mar 16, 2025 A Revolutionary Approach to Obesity and Metabolic Disorders A new weight loss treatment is on the horizon, and its set to redefine the way we manage obesity and metabolic health
Other Oral Medications: Because Rybelsus slows down gastric emptying, it can affect how other oral medications are absorbed
Some people may still lose weight while taking both medications, while others may struggle